SSWM
CELG

Smith Salley Wealth Management’s Celgene Corp CELG Stock Holding History

Smith Salley Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,158
Closed -$1.11M – 204
2019
Q3 		$1.11M Sell
11,158
-58
-0.5% -$5.51K 0.16% 94
2019
Q2 		$1.04M Sell
11,216
-218
-2% -$20.7K 0.16% 94
2019
Q1 		$1.08M Sell
11,434
-812
-7% -$71K 0.17% 93
2018
Q4 		$786K Sell
12,246
-55
-0.4% -$4.06K 0.14% 99
2018
Q3 		$1.1M Buy
12,301
+3
+0% +$265 0.17% 94
2018
Q2 		$977K Sell
12,298
-243
-2% -$20.2K 0.17% 94
2018
Q1 		$1.12M Sell
12,541
-1,956
-13% -$188K 0.2% 88
2017
Q4 		$1.51M Sell
14,497
-610
-4% -$68.8K 0.27% 83
2017
Q3 		$2.2M Sell
15,107
-740
-5% -$101K 0.42% 77
2017
Q2 		$2.06M Sell
15,847
-1,594
-9% -$195K 0.41% 81
2017
Q1 		$2.17M Sell
17,441
-1,506
-8% -$180K 0.44% 77
2016
Q4 		$2.19M Sell
18,947
-940
-5% -$105K 0.46% 76
2016
Q3 		$2.08M Sell
19,887
-1,064
-5% -$115K 0.46% 73
2016
Q2 		$2.07M Sell
20,951
-2,062
-9% -$213K 0.48% 67
2016
Q1 		$2.3M Sell
23,013
-1,922
-8% -$198K 0.58% 59
2015
Q4 		$2.99M Sell
24,935
-668
-3% -$77.3K 0.74% 47
2015
Q3 		$2.77M Sell
25,603
-1,082
-4% -$134K 0.75% 45
2015
Q2 		$3.09M Sell
26,685
-2,524
-9% -$289K 0.79% 45
2015
Q1 		$3.37M Sell
29,209
-4,966
-15% -$593K 0.86% 44
2014
Q4 		$3.82M Sell
34,175
-3,328
-9% -$351K 0.99% 38
2014
Q3 		$3.55M Sell
37,503
-3,946
-10% -$356K 0.94% 38
2014
Q2 		$3.56M Buy
+41,449
New +$3.15M 0.95% 33

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Smith Salley Wealth Management's CELG Position: Q4 2019 in Review

Smith Salley Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,158 shares — an estimated $1.11M sold.

Smith Salley Wealth Management first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $3.82M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Smith Salley Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Smith Salley Wealth Management sold 11,158 Celgene Corp shares in Q4 2019, an estimated $1.11M.
  • Smith Salley Wealth Management first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Smith Salley Wealth Management's Celgene Corp position peaked at $3.82M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Smith Salley Wealth Management's 13F filing for Q4 2019, filed 27 Jan 2020.